115 results
8-K
EX-1.1
TPST
Tempest Therapeutics Inc
20 Jun 24
Tempest Unveils New Survival Data for Amezalpat (TPST-1120) in Randomized First-Line HCC Study Demonstrating a Six-Month Improvement over Control Arm
8:13am
or the Prospectus, the Company and its subsidiaries and any “employee benefit plan” (as defined under the Employee Retirement Income Security Act of 1974
8-K
EX-4.1
cji3qbfo svg1pg
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
8-K
EX-10.1
v476dwa9
21 Jun 22
Departure of Directors or Certain Officers
7:31am